SIRT1 and diabetic kidney disease: Arctigenin was found to inhibit nuclear factor-κB (NF-κB) phosphorylation, a primary proinflammatory pathway activated in human diabetic kidney diseased kidneys, through activation of Sirtuin 1 (Sirt1).